Clinical Laserthermia Systems
5,18 SEK +0,29%1 investor følger denne virksomhed
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Omsætning
8,27 mio.
EBIT %
-797,22 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CLS B
Daglig lav / høj pris
5,001 / 5,757
SEK
Markedsværdi
72,17 mio. SEK
Aktieomsætning
286,13 t SEK
Volumen
55 t
Finanskalender
Ekstraordinær generalforsamling
21.10.2024
Delårsrapport
15.11.2024
Årsrapport
21.02.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| Avanza Pension | 6,8 % | 6,8 % |
| Nordnet Pensionsförsäkring | 6,7 % | 6,7 % |
| Handelsbanken Liv Försäkringsaktiebolag | 5,6 % | 5,6 % |
| Ålandsbanken | 3,9 % | 3,8 % |
| Arne Håkanson | 2,6 % | 2,6 % |
| Deutsche Bank AG | 2,5 % | 2,5 % |
| Anders Berthag | 1,3 % | 1,3 % |
| Rickard Danielsson | 1,1 % | 1,0 % |
| Sven Lennartsson | 1,0 % | 1,0 % |
| Harry Sjöblom | 1,0 % | 1,0 % |
ViserAlle indholdstyper
CLS: Notice of Extraordinary General Meeting at Clinical Laserthermia Systems
CLS announces proposal for changes to the Board of Directors
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools